Huayu Jiedu Formula (FTFY-919) Granules Versus Traditional Decoction for Acute Hypertensive Intracerebral Hemorrhage

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.

Also called NCT07801599

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07801599
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07801599. Randomized; quadruple masking; primary purpose treatment. Start 2026-09 (anticipated); primary completion 2027-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Huayu Jiedu Formula (FTFY-919) Granules Versus Traditional Decoction for Acute Hypertensive Intracerebral Hemorrhage
Acronym
CHAIN3
Condition
Intracerebral Hemorrhage
Condition
Hypertension
Intervention (Drug)
Huayu Jiedu Formula (FTFY-919) Granules
Intervention (Drug)
Huayu Jiedu Formula (FTFY-919) Traditional Decoction
Intervention (Drug)
Placebo Granules
Lead sponsor
Guangzhou University of Traditional Chinese Medicine (class: other)
Collaborator
Guangdong Provincial Natural Science Foundation Management Committee (class: not stated)
Collaborator
Guangdong Provincial Hospital of Traditional Chinese Medicine (class: other)

Record details

Record id
cardio:ct-nct07801599
Content hash
39aab02dec189416e44dd391dbaf68fb48c4a63674a86054a2f41af825380190